2016 Access DEA Programs 
NORML
SEPTEMBER 20, 2019
We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. It’s been nearly three years since the DEA announced its revolutionary cultivator program. The only problem is, the program doesn’t actually exist.
WeedAdvisor
AUGUST 28, 2019
The applications were submitted as far back as 2016. Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action. Dozens of Applications”. .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
MARCH 30, 2022
In 2016, the Agency announced that it would expand the pool of federally licensed growers beyond just the University of Mississippi (which was initially granted a federal cannabis cultivation license in 1968). Senate members in 2020 passed a similar version of S. 253 in the final weeks of the legislative session. The full text of S.
Cannabis Law Report
MAY 29, 2022
8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. In addition to the arduous FDA approval process, potential psychedelic therapies would also require complying with requirements from the Drug Enforcement Administration (DEA). 2] David E.
Veriheal
AUGUST 19, 2022
” Cannabis Research Should Be Based on Real, Accessible Products. In February 2021, a lawsuit was filed against the DEA for prohibiting access for others aside from the University of Mississippi to cultivate cannabis for research purposes. Do researchers need access to consistent market-quality cannabis for research?
Cannabis Law Report
APRIL 8, 2022
Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. The MDMA Therapy Training Program was created to train the next generation of psychedelic therapists. Lyle Craker, Ph.D., Reddit awarded $82,765.95 MAPS Founder Rick Doblin, Ph.D.,
SMPL
AUGUST 14, 2019
That includes a lack of access to financial services that lead such companies to operate on a largely cash basis, making them targets for crime. ABA noted that the Drug Enforcement Administration (DEA) announced in 2016 that it is accepting applications for additional cannabis manufacturers, which could bolster research, for example.
Expert insights. Personalized for you.
227 
Let's personalize your content